Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonresectable Pancreatic Cancer”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT00245362
What this trial is testing

A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerNonresectable Pancreatic Cancer
Cell Genesys 50
Large-scale testing (Phase 3)Study completedNCT00044031
What this trial is testing

Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Cancer Advances Inc. 394
Early research (Phase 1)Looking for participantsNCT07481383
What this trial is testing

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectable
Continuity Biosciences, LLC 12
Testing effectiveness (Phase 2)WithdrawnNCT00487851
What this trial is testing

Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract NeoplasmsDuodenal Neoplasms
Karolinska Institutet

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation